Cervical cancer develops through persistent infection with high-risk human papilloma virus
(hrHPV) and is a leading cause of death among women worldwide and in the United States …

Cervical cancer screening will rely, increasingly, on HPV testing as a primary screen. The
requirement for triage tests which can delineate clinically significant infection is thus …

Cervical cancer is the leading cause of death among women with cancer worldwide. Here,
we performed an integrative analysis of Illumina HumanMethylation450K and RNA-seq data …

The increase in recent scientific studies on cancer biomarkers has brought great new
insights into the field. Moreover, novel technological breakthroughs such as long read …

This review is based on the recent EUROGIN scientific session:“Assessing risk of cervical
cancer in the post‐vaccination era,” which addressed the demands of cervical intraepithelial …

Cervical cancer is the most prevalent gynecologic malignancy, especially in women of low-
and middle-income countries (LMICs). With a better understanding of the etiology and …

DNA methylation analysis of cervical scrapes using FAM19A4 and mir124‐2 genes has
shown a good clinical performance in detecting cervical cancer and advanced CIN lesions …

Background There is no prognostic test to ascertain whether cervical intraepithelial
neoplasias (CINs) regress or progress. The majority of CINs regress in young women, and …

Recent discoveries have led to the development of novel ideas and techniques that have
helped elucidate the correlation between epigenetics and tumor biology. Nowadays, the …

Cervical cancer is one of the common malignancies in women worldwide. Exploration of
pathogenesis and molecular mechanism of cervical cancer is pivotal for development of …